3422 Shares in Paylocity Holding Corp (PCTY) Acquired by Verition Fund Management LLC

Acadian Asset Management LLC bought a new position in shares of Paylocity during the 3rd quarter valued at approximately $143,000. Quantbot …

Paylocity logoVerition Fund Management LLC purchased a new position in Paylocity Holding Corp (NASDAQ:PCTY) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 3,422 shares of the software maker’s stock, valued at approximately $275,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Tower Research Capital LLC TRC bought a new stake in Paylocity in the 2nd quarter worth approximately $102,000. NumerixS Investment Technologies Inc increased its position in shares of Paylocity by 2,000.0% during the 2nd quarter. NumerixS Investment Technologies Inc now owns 2,100 shares of the software maker’s stock valued at $124,000 after purchasing an additional 2,000 shares during the last quarter. Acadian Asset Management LLC bought a new position in shares of Paylocity during the 3rd quarter valued at approximately $143,000. Quantbot Technologies LP bought a new position in shares of Paylocity during the 3rd quarter valued at approximately $168,000. Finally, Cambridge Investment Research Advisors Inc. bought a new position in shares of Paylocity during the 3rd quarter valued at approximately $215,000. 63.79% of the stock is currently owned by institutional investors.

Shares of NASDAQ PCTY traded up $0.30 during mid-day trading on Wednesday, reaching $66.57. 252,900 shares of the company were exchanged, compared to its average volume of 197,967. The stock has a market capitalization of $3.50 billion, a P/E ratio of 213.87, a price-to-earnings-growth ratio of 5.64 and a beta of 2.03. Paylocity Holding Corp has a 1 year low of $41.15 and a 1 year high of $88.47.

Paylocity (NASDAQ:PCTY) last issued its quarterly earnings data on Thursday, November 1st. The software maker reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. Paylocity had a return on equity of 12.35% and a net margin of 12.08%. The firm had revenue of $100.50 million during the quarter, compared to analysts’ expectations of $98.37 million. During the same period in the prior year, the business posted $0.15 EPS. The firm’s quarterly revenue was up 23.3% on a year-over-year basis. Analysts predict that Paylocity Holding Corp will post 0.59 EPS for the current year.

Several equities analysts have commented on PCTY shares. Jefferies Financial Group started coverage on Paylocity in a research report on Monday, October 1st. They issued a “hold” rating and a $88.00 price objective on the stock. Bank of America upped their price objective on Paylocity from $73.00 to $91.00 and gave the company a “buy” rating in a research report on Wednesday, September 26th. BidaskClub downgraded Paylocity from a “hold” rating to a “sell” rating in a research report on Monday, October 15th. Zacks Investment Research downgraded Paylocity from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 10th. Finally, Robert W. Baird upped their target price on Paylocity from $68.00 to $71.00 and gave the stock an “outperform” rating in a report on Friday, November 2nd. Six research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Paylocity presently has an average rating of “Buy” and a consensus target price of $68.36.

In related news, Director Steven I. Sarowitz sold 72,500 shares of the company’s stock in a transaction dated Friday, November 9th. The stock was sold at an average price of $62.78, for a total transaction of $4,551,550.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Steven I. Sarowitz sold 80,000 shares of the stock in a transaction dated Tuesday, November 6th. The shares were sold at an average price of $61.65, for a total value of $4,932,000.00. Following the completion of the transaction, the director now directly owns 14,771,651 shares in the company, valued at $910,672,284.15. The disclosure for this sale can be found here. Insiders have sold a total of 183,109 shares of company stock worth $11,527,499 over the last ninety days. 41.20% of the stock is currently owned by corporate insiders.

WARNING: This news story was originally posted by Fairfield Current and is owned by of Fairfield Current. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://www.fairfieldcurrent.com/news/2019/01/23/verition-fund-management-llc-invests-275000-in-paylocity-holding-corp-pcty.html.

Paylocity Profile

Paylocity Holding Corporation provides cloud-based payroll and human capital management software solutions for medium-sized organizations in the United States. The company offers Paylocity Web Pay for enterprise-grade payroll processing and administration; Paylocity Web HR for employee record management, HR compliance and reporting, HR insight and analytics, and self-service portals; Talent Management for employee performance appraisal process and performance review; Paylocity Web Time, a time and attendance solution; and Paylocity Web Expense, an expense management tool designed to streamline and automate the expense management process.

Featured Story: What is a closed-end mutual fund (CEF)?

Institutional Ownership by Quarter for Paylocity (NASDAQ:PCTY)

Receive News & Ratings for Paylocity Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Paylocity and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Renaissance Technologies LLC Has $13.04 Million Holdings in Flushing Financial Co. (FFIC)

Renaissance Technologies LLC decreased its holdings in shares of Flushing Financial Co. (NASDAQ:FFIC) by 1.3% in the 3rd quarter, according to …

Flushing Financial logoRenaissance Technologies LLC decreased its holdings in shares of Flushing Financial Co. (NASDAQ:FFIC) by 1.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 534,260 shares of the bank’s stock after selling 6,800 shares during the period. Renaissance Technologies LLC owned approximately 1.91% of Flushing Financial worth $13,036,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of the company. SG Americas Securities LLC purchased a new stake in shares of Flushing Financial in the second quarter worth approximately $176,000. Brown Advisory Inc. purchased a new stake in shares of Flushing Financial in the third quarter worth approximately $293,000. Citadel Advisors LLC lifted its position in shares of Flushing Financial by 56.6% in the second quarter. Citadel Advisors LLC now owns 19,421 shares of the bank’s stock worth $506,000 after purchasing an additional 7,016 shares in the last quarter. Blair William & Co. IL purchased a new stake in shares of Flushing Financial in the third quarter worth approximately $514,000. Finally, GSA Capital Partners LLP lifted its position in shares of Flushing Financial by 38.0% in the second quarter. GSA Capital Partners LLP now owns 27,701 shares of the bank’s stock worth $723,000 after purchasing an additional 7,635 shares in the last quarter. Institutional investors own 77.28% of the company’s stock.

FFIC stock traded down $0.05 during midday trading on Wednesday, hitting $22.03. 43,700 shares of the company traded hands, compared to its average volume of 58,347. Flushing Financial Co. has a twelve month low of $20.27 and a twelve month high of $29.55. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 2.21. The company has a market cap of $627.79 million, a PE ratio of 14.03, a price-to-earnings-growth ratio of 1.10 and a beta of 0.88.

Flushing Financial (NASDAQ:FFIC) last announced its quarterly earnings results on Tuesday, October 23rd. The bank reported $0.54 EPS for the quarter, beating the consensus estimate of $0.48 by $0.06. Flushing Financial had a return on equity of 9.27% and a net margin of 18.44%. The company had revenue of $46.48 million for the quarter, compared to the consensus estimate of $44.70 million. As a group, equities analysts expect that Flushing Financial Co. will post 1.83 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, December 28th. Shareholders of record on Friday, December 7th were issued a dividend of $0.20 per share. The ex-dividend date was Thursday, December 6th. This represents a $0.80 annualized dividend and a yield of 3.63%. Flushing Financial’s dividend payout ratio (DPR) is presently 50.96%.

A number of analysts have recently issued reports on FFIC shares. BidaskClub raised shares of Flushing Financial from a “sell” rating to a “hold” rating in a research report on Tuesday, October 30th. Zacks Investment Research raised shares of Flushing Financial from a “sell” rating to a “hold” rating in a research report on Tuesday, October 9th. Finally, ValuEngine lowered shares of Flushing Financial from a “hold” rating to a “sell” rating in a research report on Saturday. One analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $29.38.

TRADEMARK VIOLATION WARNING: “Renaissance Technologies LLC Has $13.04 Million Holdings in Flushing Financial Co. (FFIC)” was published by Fairfield Current and is the sole property of of Fairfield Current. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://www.fairfieldcurrent.com/news/2019/01/23/flushing-financial-co-ffic-stake-decreased-by-renaissance-technologies-llc.html.

Flushing Financial Company Profile

Flushing Financial Corporation operates as the bank holding company for Flushing Bank that provides banking products and services primarily to consumers, businesses, and governmental units. The company offers various deposit products, including checking and savings accounts, money market accounts, demand accounts, NOW accounts, and certificates of deposit.

Further Reading: What is the S&P 500 Index?

Institutional Ownership by Quarter for Flushing Financial (NASDAQ:FFIC)

Receive News & Ratings for Flushing Financial Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Flushing Financial and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

BlackRock Inc. Invests $127.19 Million in Veoneer Inc (NYSE:VNE)

BlackRock Inc. bought a new stake in Veoneer Inc (NYSE:VNE) in the third quarter, according to its most recent filing with the Securities & Exchange …

Veoneer logoBlackRock Inc. bought a new stake in Veoneer Inc (NYSE:VNE) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 2,309,688 shares of the company’s stock, valued at approximately $127,194,000. BlackRock Inc. owned about 2.65% of Veoneer as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Northern Trust Corp bought a new position in Veoneer in the second quarter worth about $1,053,000. Bank of Montreal Can purchased a new stake in Veoneer in the third quarter worth approximately $300,000. Nikko Asset Management Americas Inc. purchased a new position in shares of Veoneer during the 3rd quarter worth $7,478,000. Gateway Investment Advisers LLC purchased a new position in shares of Veoneer during the 3rd quarter worth $3,033,000. Finally, Nisa Investment Advisors LLC purchased a new position in shares of Veoneer during the 3rd quarter worth $531,000. Institutional investors and hedge funds own 27.85% of the company’s stock.

VNE traded down $1.25 during midday trading on Wednesday, hitting $29.45. 486,196 shares of the company traded hands, compared to its average volume of 680,760. The company has a quick ratio of 2.35, a current ratio of 2.62 and a debt-to-equity ratio of 0.01. Veoneer Inc has a 52-week low of $22.63 and a 52-week high of $57.93.

Veoneer (NYSE:VNE) last posted its quarterly earnings data on Thursday, October 25th. The company reported ($0.78) earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.78). The company had revenue of $526.00 million for the quarter, compared to analysts’ expectations of $532.60 million. Equities research analysts expect that Veoneer Inc will post -2.93 EPS for the current year.

A number of brokerages have issued reports on VNE. Zacks Investment Research downgraded shares of Veoneer from a “hold” rating to a “sell” rating in a report on Saturday, January 5th. Jefferies Financial Group raised shares of Veoneer from a “hold” rating to a “buy” rating and lowered their price objective for the company from $50.00 to $42.00 in a research report on Thursday, November 8th. BMO Capital Markets lowered their price target on shares of Veoneer from $60.00 to $49.00 and set an “outperform” rating for the company in a research report on Monday, November 5th. They noted that the move was a valuation call. Longbow Research upgraded shares of Veoneer from a “neutral” rating to a “buy” rating and set a $40.00 price objective for the company in a research note on Monday, January 14th. Finally, Barclays set a $35.00 price target on shares of Veoneer and gave the company a “buy” rating in a research note on Friday, January 4th. Six equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the company. Veoneer has an average rating of “Hold” and a consensus target price of $42.53.

WARNING: This story was published by Fairfield Current and is owned by of Fairfield Current. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://www.fairfieldcurrent.com/news/2019/01/23/blackrock-inc-purchases-new-position-in-veoneer-inc-vne.html.

Veoneer Company Profile

Veoneer, Inc designs, develops, manufactures, and sells automotive safety electronics products. The company offers automotive radars, cameras with driver assist systems, night vision systems, positioning systems, restraint control, sensing, and brake systems. The company is based in Stockholm, Sweden.

Read More: How accurate is the Rule of 72?

Institutional Ownership by Quarter for Veoneer (NYSE:VNE)

Receive News & Ratings for Veoneer Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Veoneer and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

AngioDynamics, Inc. (ANGO) Shares Bought by Tributary Capital Management LLC

Acadian Asset Management LLC lifted its stake in AngioDynamics by 15.8% in the third quarter. Acadian Asset Management LLC now owns 302,068 …

AngioDynamics logoTributary Capital Management LLC boosted its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 1.4% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 503,670 shares of the medical instruments supplier’s stock after purchasing an additional 6,895 shares during the period. Tributary Capital Management LLC owned about 1.36% of AngioDynamics worth $10,139,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Wells Fargo & Company MN grew its position in AngioDynamics by 2.0% during the third quarter. Wells Fargo & Company MN now owns 1,103,646 shares of the medical instruments supplier’s stock valued at $23,993,000 after purchasing an additional 21,218 shares in the last quarter. Nordea Investment Management AB lifted its stake in AngioDynamics by 27.8% in the third quarter. Nordea Investment Management AB now owns 208,523 shares of the medical instruments supplier’s stock valued at $4,533,000 after acquiring an additional 45,410 shares during the last quarter. Acadian Asset Management LLC lifted its stake in AngioDynamics by 15.8% in the third quarter. Acadian Asset Management LLC now owns 302,068 shares of the medical instruments supplier’s stock valued at $6,568,000 after acquiring an additional 41,279 shares during the last quarter. Heartland Advisors Inc. lifted its stake in AngioDynamics by 41.0% in the third quarter. Heartland Advisors Inc. now owns 503,827 shares of the medical instruments supplier’s stock valued at $10,953,000 after acquiring an additional 146,498 shares during the last quarter. Finally, WINTON GROUP Ltd acquired a new stake in AngioDynamics in the third quarter valued at approximately $1,528,000. 98.80% of the stock is currently owned by hedge funds and other institutional investors.

ANGO has been the subject of a number of analyst reports. BidaskClub upgraded shares of AngioDynamics from a “buy” rating to a “strong-buy” rating in a research note on Friday, September 28th. Canaccord Genuity lifted their target price on shares of AngioDynamics from $20.00 to $23.00 and gave the company a “hold” rating in a research note on Monday, January 7th. Finally, Zacks Investment Research upgraded shares of AngioDynamics from a “hold” rating to a “strong-buy” rating and set a $24.00 target price for the company in a research note on Wednesday. Two research analysts have rated the stock with a hold rating, two have given a buy rating and two have issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $21.11.

In other news, CFO Michael Greiner sold 1,939 shares of the business’s stock in a transaction on Wednesday, November 7th. The shares were sold at an average price of $21.53, for a total value of $41,746.67. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.80% of the stock is currently owned by insiders.

Shares of AngioDynamics stock traded down $0.13 on Wednesday, reaching $20.81. The stock had a trading volume of 1,645 shares, compared to its average volume of 199,012. The company has a current ratio of 2.88, a quick ratio of 1.86 and a debt-to-equity ratio of 0.25. AngioDynamics, Inc. has a fifty-two week low of $15.26 and a fifty-two week high of $24.49. The stock has a market capitalization of $775.42 million, a price-to-earnings ratio of 28.15 and a beta of 0.74.

AngioDynamics (NASDAQ:ANGO) last issued its quarterly earnings data on Friday, January 4th. The medical instruments supplier reported $0.22 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.21 by $0.01. AngioDynamics had a net margin of 5.10% and a return on equity of 5.85%. The business had revenue of $91.50 million during the quarter, compared to analysts’ expectations of $89.24 million. During the same period in the previous year, the company earned $0.16 earnings per share. AngioDynamics’s revenue for the quarter was up 5.5% on a year-over-year basis. As a group, research analysts predict that AngioDynamics, Inc. will post 0.86 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This story was first published by Fairfield Current and is the property of of Fairfield Current. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.fairfieldcurrent.com/news/2019/01/23/angiodynamics-inc-ango-shares-bought-by-tributary-capital-management-llc.html.

AngioDynamics Profile

AngioDynamics, Inc designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support.

See Also: What are the benefits of momentum investing?

Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for AngioDynamics and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Oxford Square Capital (OXSQ) Given a $5.00 Price Target by Barclays Analysts

Millennium Management LLC increased its position in Oxford Square Capital by 136.9% during the second quarter. Millennium Management LLC now …

Oxford Square Capital logoOxford Square Capital (NASDAQ:OXSQ) has been assigned a $5.00 price target by equities researchers at Barclays in a research report issued on Tuesday. The firm currently has a “sell” rating on the stock. Barclays‘s target price would indicate a potential downside of 20.89% from the stock’s current price.

A number of other analysts also recently issued reports on the company. Zacks Investment Research raised Oxford Square Capital from a “hold” rating to a “buy” rating and set a $7.50 target price on the stock in a research report on Thursday, November 15th. TheStreet downgraded Oxford Square Capital from a “b-” rating to a “c+” rating in a research report on Friday, November 2nd. Finally, National Securities reaffirmed a “sell” rating and issued a $5.00 target price on shares of Oxford Square Capital in a research report on Monday, November 5th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $5.83.

Shares of NASDAQ:OXSQ traded down $0.01 during midday trading on Tuesday, reaching $6.32. The company had a trading volume of 52,147 shares, compared to its average volume of 168,086. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.18 and a current ratio of 0.18. The company has a market cap of $306.52 million, a P/E ratio of 10.53 and a beta of 0.50. Oxford Square Capital has a 1-year low of $5.15 and a 1-year high of $7.52.

Oxford Square Capital (NASDAQ:OXSQ) last released its earnings results on Tuesday, October 30th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. The business had revenue of $15.15 million for the quarter, compared to the consensus estimate of $14.44 million. Oxford Square Capital had a return on equity of 8.99% and a net margin of 75.91%. As a group, equities analysts predict that Oxford Square Capital will post 0.69 earnings per share for the current fiscal year.

A number of hedge funds and other institutional investors have recently made changes to their positions in OXSQ. Advisors Asset Management Inc. acquired a new position in Oxford Square Capital during the second quarter worth approximately $3,314,000. Marshall Wace LLP acquired a new position in Oxford Square Capital during the third quarter worth approximately $1,416,000. Millennium Management LLC increased its position in Oxford Square Capital by 136.9% during the second quarter. Millennium Management LLC now owns 136,289 shares of the company’s stock worth $940,000 after buying an additional 78,760 shares during the last quarter. Russell Investments Group Ltd. acquired a new position in Oxford Square Capital during the second quarter worth approximately $183,000. Finally, Mackenzie Financial Corp increased its position in Oxford Square Capital by 73.1% during the third quarter. Mackenzie Financial Corp now owns 59,440 shares of the company’s stock worth $423,000 after buying an additional 25,106 shares during the last quarter. 14.79% of the stock is currently owned by hedge funds and other institutional investors.

About Oxford Square Capital

Oxford Square Capital Corp. is a business development company, which engages in the provision of capital to established businesses, investing in syndicated bank loans and purchasing debt and equity tranches of collateralized loan obligations. The company was founded on July 21, 2003 and is headquartered in Greenwich, CT.

Recommended Story: Should You Consider an Index Fund?

Receive News & Ratings for Oxford Square Capital Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Oxford Square Capital and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts